Thromboembolic risk with JAK inhibitors in atopic dermatitis: Context, caution and clinical relevance

Documenti analoghi

• Correspondence to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis’
  di: Shiuan‐Chih Chen, et al.
  Pubblicazione: (2025)
• Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
  di: Sheng Li, et al.
  Pubblicazione: (2025)
• Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study
  di: Khalaf Kridin, et al.
  Pubblicazione: (2025)
• Response to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study’
  di: Marion Gundelwein, et al.
  Pubblicazione: (2025)
• Critical methodological enhancements for JAK inhibitor safety studies in atopic dermatitis
  di: Zheying Huang, et al.
  Pubblicazione: (2025)